Early Career Group Social Event

8:30 am

Registration

9:00 am

• President's Welcome and Introduction
  President's Welcome and Introduction
  • Professor Shauna Culshaw
    Professor Shauna Culshaw

    Professor

    Shauna Culshaw is Professor of Periodontology and Immunology at the University of Glasgow, where she is Dental Clinical Research Facility Lead, Lead for Undergraduate teaching in Periodontics and Deputy Head of the Dental School. Shauna completed specialist training in Periodontics and treats patients referred to Glasgow Dental Hospital with advanced periodontal diseases and provides specialist training to staff. Shauna and her research team investigate the immune response in the oral cavity and the relationship between periodontitis and systemic inflammatory diseases. 

    

9:15 am

• Immune diseases - from pathogenetic insight to future cure
  Immune diseases - from pathogenetic insight to future cure

  • To review recent progress in understanding pathogenesis of immune mediated diseases and the therapeutic advances that have arisen thereby.

  • To be able to describe the spectrum of immune mediated diseases (IMIDs).

  • To be able to describe the key immune and stromal pathways driving IMIDs that have been permissive to the development of new therapeutics.

  • To be able to discuss the potential in future for the achievement of long-term remission in IMIDs and the possibility of cure.

  • Understanding of state-of-the-art pathogenesis dissection of complex human disease to develop novel therapeutics.

  GDC Development Outcome:

  C

  • Professor Iain McInnes
    Professor Iain McInnes

    Professor

    Iain McInnes is Head of College of Medical Veterinary and Life Sciences, and Vice Principal, University of Glasgow, and serves also as the Muirhead Professor of Medicine and Arthritis UK Professor of Rheumatology in the University. He is past director of the Versus Arthritis Centre of Excellence for Inflammatory Arthritis, lead from the University of Glasgow that includes Universities of Oxford, Newcastle and Birmingham. He is a Trustee on the Board of Arthritis-UK. He is past Chairman of Foreum (Foundation for European Rheumatology Research) Scientific Committee and now sits on Foreum Board as a trustee. He is Past-President of the European Alliance of Rheumatology Associations (EULAR). Under these auspices he led the creation of the first pan-European Rheumatology Research Centre launched in 2021.  His work is mainly focused upon the understanding of the pathogenesis of immune mediated inflammatory diseases and encompasses basic discovery immunology through phase 1 and proof of concept experimental medicine clinical trials to leadership of pivotal phase 3 trials in the area of immune biology. He has served on a number of scientific advisory groups adjacent to the pharmaceutical industry, mainly in the area of development of novel immune modifying agents. He has published >650 peer-reviewed original and review articles with an h-index of >160 equating to >125,000 citations.  He is a Fellow of the Royal Society of Edinburgh and Fellow of the Academy of Medical Sciences. He was made Commander of the Order of the British Empire (CBE) in 2019 by HM Queen Elizabeth II.

    

10:00 am

• Advanced therapies in IBD: What the Dental Team Really Needs to Know
  Advanced therapies in IBD: What the Dental Team Really Needs to Know

  To demystify the advanced therapies in IBD and how they could impact on planned dental treatment.

  1. To give a brief overview of modern IBD management.

  2. To explain the drugs used to manage IBD.

  3. To give clear guidance on peri-operative advanced therapy management.

  To understand the advanced therapies in IBD and how they could impact on planned dental surgery.

  GDC Development Outcomes: 

  A,B & C 

  • Professor Daniel Gaya
    Professor Daniel Gaya

    Professor

    Professor Gaya is a consultant gastroenterologist at Glasgow Royal Infirmary. He is clinical lead for the NRS Gastroenterology Research Network and has an NRS senior research fellowship to research inflammatory bowel disease (IBD). He runs the academic and commercial trial portfolio for IBD research at Glasgow Royal Infirmary and has supervises fellows undertaking MDs in IBD research. He has authored many papers over the years and published national guidance on the management of IBD via the British Society of Gastroenterology (BSG). Professor Gaya also runs a busy NHS IBD service and is clinical lead for Gastroenterology in NE Glasgow.  He receives tertiary referrals for the management of IBD and is a member of the transition IBD team the care of 16–18-year-olds with IBD at the Royal Hospital for Children in Glasgow. 

    

10:45 am

Refreshments and Trade Exhibition

11:15 am

• Host Modulation Therapies: Translation from Bench to Clinic
  Host Modulation Therapies: Translation from Bench to Clinic

  The inflammatory response protects the host by containing foreign invaders. Excessive inflammation is now considered pathophysiologic in many chronic diseases, including vascular and neurodegenerative diseases, metabolic syndrome, rheumatoid arthritis, and periodontal diseases, and thus a significant public health concern. Because the acute inflammatory response is protective, it is ideally self-limited and resolves completely, enabling a return to homeostasis. Homeostasis is a fundamental characteristic of living things. It is the maintenance of the internal environment within tolerable limits and is often described as a process of balance. With the identification of pro-resolving mediators, growing evidence shows that resolution of self-limited inflammation is an active, programmed response that is “turned on”.  This presentation will focus on inflammation as a central driver of periodontal disease and a mediator between microbial challenge and tissue destruction.  In this context, the presentation will review the importance of regulating host responses in maintaining oral health and evidence from recent human and preclinical studies on pro-resolving mediators as novel therapeutic approaches.  

  1. Review basic mechanisms of resolving inflammation

  2. Identify the differences in therapeutic approaches based on current concepts in inflammation and resolution of inflammation

  3. Understand the rationale and the current evidence behind the use of host modulators for periodontal therapy

  4. Explore the apparent bidirectionality of periodontal-microbial dysbiosis and chronic non-resolving inflammation

  5. Gain strategies for pro-resolution approaches to manage inflammation

  GDC Development Outcome:

  C

  • Professor Hatice Hasturk
    Professor Hatice Hasturk

    Professor

    Dr. Hatice Hasturk is a Professor in the Department of Immunology and Inflammation and the director of the Center for Clinical and Translational Research at the ADA Forsyth Institute. She also holds an adjunct associate professor position at the Boston University School of Dental Medicine. She earned her dental degree and Ph.D. in Periodontology from Hacettepe University, Turkey, and a certificate of advanced graduate studies in periodontology from Boston University. She is a board-certified periodontist who practices alongside her research activities. Dr. Hasturk’s research has focused on the mechanisms linking periodontitis to systemic inflammatory diseases, including diabetes and cardiovascular disease, as well as the treatment of periodontitis by regulating the inflammatory response. She has received NIH and Industry grants to study inflammation and novel therapeutics for resolving inflammation. Her research focus has been on translational research since the early 2000s, supported by grants from the NIH/NIDCR, industry, and foundations. She has authored/co-authored 151+ original articles, numerous abstracts, and book chapters in peer-reviewed journals. Dr. Hasturk is the recipient of the 2016 International Association of Dental Research (IADR) William Geis Award, the 2020 American Academy of Periodontology (AAP) Clinical Research Award, and the 2020-2021 American Dental Association (ADA) Norton Ross Award for Excellence in Clinical Research. She is a member of the IADR, AAP, ADA, European Federation of Periodontology, and International Academy of Periodontology.

    

12:00 pm

• Panel Disucssion
  Panel Disucssion

12:15 pm

• Patient Forum Session
  Patient Forum Session

12:45 pm

Lunch Break and Trade Exhibition

2:00 pm

• Hidden in plain sight: periodontal bar codes for systemic conditions
  Hidden in plain sight: periodontal bar codes for systemic conditions

  • To illustrate the range of non-plaque-induced periodontal conditions, way beyond the 2018 classification.

  • To share a new classification for non-plaque-induced periodontal conditions in children, adolescents and adults.

  • To provide a systematic approach to elucidating differential diagnoses of medical conditions that present within the (para-) periodontal tissues.

  • Be able to summarise the classification of non-plaque-induced periodontal conditions.

  • Be able to practically implement a simple diagnostic algorithm.

  • Be aware of special Investigations that can help achieve a definitive diagnosis for medical conditions presenting in the periodontium.

  • Be able to make a differential diagnosis and understand management indications.

  GDC Development Outcome:

  C

  • Professor Iain Chapple
    Professor Iain Chapple

    Professor

    Iain Chapple is Professor of Periodontology, former Head of the School of Dentistry and Director of Research for the Institute of Clinical Science, University of Birmingham UK. Iain is former Scientific Editor of: the British Dental Journal; Journal of Periodontal Research and current Associate Editor of: Journal Clinical Periodontology and Periodontology 2000. He has written 15-textbooks and 44 book chapters. Iain served the IADR Periodontal Research Group (PRG) as President (2006-7), Group Chair (2008-1015) and Counsellor (2016). He served the European Federation of Periodontology (EFP) as: Treasurer (2007-2013); Workshop co-chair (2008-current); Foundation Chair of the EFP Scientific Advisory Committee; Editor of JCP Digest (2014-2016); EFP Secretary General (2016-2019). He was British Society of Periodontology President 2014-2015 and awarded the Charles Tomes medal of the Royal College of Surgeons (2011), the IADR PRG Rizzo Research Award (2001), and IADR Distinguished Scientist in Periodontal Research (2018). He was awarded the special citation award of the American Academy of Periodontology 2018 and an MBE in the Queen’s 2022 New Year’s honours list. Iain has published over 350 peer reviewed manuscripts in the international scientific literature and was named on the prestigious Clarivate Highly Cited Researchers 2025 list for cross-field research.

    

2:45 pm

• Managing mobile teeth and occlusion in patients with periodontitis
  Managing mobile teeth and occlusion in patients with periodontitis

  Patients with stage IV periodontitis present with advanced attachment loss, increased tooth mobility, pathological tooth migration and often secondary occlusal trauma. Their masticatory function is compromised and tooth loss is common. Even so, the EFP S3 Clinical Practice Guideline for stage IV periodontitis makes clear that successful periodontal therapy can keep many severely compromised teeth functional over the long term. Tooth maintenance should therefore be the primary goal, and extraction should be decided only after the response to periodontal therapy has been reassessed.

  This presentation covers the guideline recommendations that apply to the management of mobile teeth and occlusion within the interdisciplinary treatment of stage IV periodontitis:

  • Splinting: splinting mobile teeth only to improve patient comfort and chewing function.

  • Occlusal adjustment: selective grinding of premature contacts and interferences in cases of occlusal trauma.

  • Provisional restorations: fixed or removable temporaries during active periodontal therapy and the re-evaluation phase.

  Clinical cases show how to examine occlusion in practice, including fremitus, premature contacts, excursive interferences and functional mobility. The presentation explains when and how mobility should be addressed, and when it is better left untreated. It also shows how provisional solutions can stabilise the dentition, restore function and aesthetics, and keep definitive prosthodontic decisions open until periodontal stability has been confirmed.

  1. To demonstrate tooth maintenance as the guiding principle in stage IV periodontitis, based on the EFP S3 Guideline.

  2. To present evidence-based strategies for managing increased tooth mobility and occlusal trauma.

  3. To show the role of fixed and removable provisional restorations in the interdisciplinary treatment sequence.

  • To review the EFP S3 Guideline recommendations on splinting, occlusal adjustment and provisional restorations in stage IV periodontitis.

  • To differentiate increased from increasing tooth mobility, and primary from secondary occlusal trauma.

  • To demonstrate a systematic clinical occlusal examination.

  • To discuss the indications, designs and limitations of splints and of fixed and removable temporaries.

  At the end of the presentation, participants will be able to:

  • Assess tooth mobility and occlusal contacts in periodontally compromised patients and identify signs of occlusal trauma;

  • Decide when splinting of mobile teeth is indicated for patient comfort and function, and select a suitable splint design;

  • Identify and selectively eliminate premature contacts and interferences by occlusal adjustment;

  • Plan fixed or removable provisional restorations that support periodontal healing and allow a later decision on tooth maintenance versus replacement;

  • Integrate occlusal management into the interdisciplinary treatment sequence for stage IV periodontitis.

  GDC Development Outcomes:

  B & C

  • Professor Nicola Zitzmann
    Professor Nicola Zitzmann

    Professor

    Nicola U. Zitzmann is Professor at the University of Basel and research group leader at the Department of Clinical Research (DKF). She chaired the Department of Reconstructive Dentistry until 2026 and now treats patients in private practice. After postgraduate training in prosthodontics in Zurich (Prof. P. Schärer, 1994–1997), she joined the University of Basel as Assistant Professor and completed her habilitation on implant-supported restorations in 2004. After a research stay in Gothenburg (Profs. J. Lindhe and T. Berglundh), she received her PhD in Periodontology in 2006. She

    is President of the Swiss Society of Reconstructive Dentistry (SSRD), Past President of the International College of Prosthodontics and board member of the Swiss Society of Oral Implantology (SGI), and chaired the ITI Section Switzerland until 2021. She has authored more than 180 original publications and 80 papers and book chapters (h-index 67). In 2014, she received the Jan Lindhe Research Award.

    

3:30 pm

Refreshments and Trade Exhibition

4:00 pm

• Navigating Evidence in the Face of Information Overload
  Navigating Evidence in the Face of Information Overload
  • Professor Philip Preshaw
    Professor Philip Preshaw

    Professor

    Professor Philip Preshaw is Editor of the British Dental Journal and Visiting Professor in Periodontology at Newcastle University. He was previously Dean of Dentistry and Professor of Periodontology at the University of Dundee. He received his dental degree from the University of Newcastle upon Tyne in 1991 and his PhD in 1997. He is a registered specialist in Periodontics and is a Fellow of the Royal College of Surgeons of Edinburgh. His main research interests are investigations of the pathogenesis of periodontal disease, and links between diabetes and periodontitis. He has been awarded a UK National Institute of Health Research (NIHR) National Clinician Scientist Fellowship, a Distinguished Scientist Award from the International Association for Dental Research, and a King James IV Professorship from the Royal College of Surgeons of Edinburgh for his contributions to dental research. He is a Past-President of the British Society of Periodontology and Implant Dentistry. 

    

4:45 pm

• Panel Disucssion
  Panel Disucssion

5:00 pm

Close

8:30 am

Registration

9:00 am

• Dental Biofilm–Induced Gingivitis: Effective, Guideline-Based Treatment in Practice
  Dental Biofilm–Induced Gingivitis: Effective, Guideline-Based Treatment in Practice

  Dental biofilm–induced gingivitis is among the most prevalent oral conditions worldwide and a key precursor to periodontitis when inadequately managed. Although largely preventable, it is frequently undertreated or addressed with generic, non-individualised protocols. This lecture presents an evidence-based synthesis of contemporary management strategies, informed by recent systematic reviews and current clinical practice guidelines, that will deliver better outcomes for patients with gingivitis. It underscores the importance of structured assessment of gingival health to guide personalised preventive care, with professional and self-performed mechanical plaque control positioned as the cornerstone of treatment. Professional mechanical plaque removal is framed as a targeted, site-specific intervention rather than a routine procedure, while self-care is addressed through the appropriate selection of oral hygiene devices matched to individual patient needs and preferences. The session further considers evidence-based behaviour change strategies to sustain long-term self-care, and the role of the whole dental team in delivering patient-centred coaching to improve gingival health outcomes.

  To provide an evidence-based overview of the personalised management of dental biofilm–induced gingivitis, integrating professional mechanical plaque removal, tailored oral hygiene instruction and practical behaviour change strategies to support sustained patient self-care.

  At the end of this session, delegates should be able to:

  • Assess dental biofilm–induced gingivitis to support early intervention and personalised patient care.

  • Apply guideline-based professional and self-performed mechanical plaque control, including appropriate selection of oral hygiene devices tailored to patient needs.

  • Implement patient-centred behaviour change strategies to improve patient motivation, adherence and long-term self-care.

  GDC Development Outcomes:

  A, B, C & D

  • Dr Jeanie Suvan
    Dr Jeanie Suvan

    Dr

    Jeanie trained as a Dental Hygienist at the University of Alberta, Canada.  Following roles in clinical practice and teaching, she moved to the Department of Periodontology, University of Bern, Switzerland, beginning her research activities.  For many years Jeanie was involved in patient care, post-graduate teaching and clinical research at UCL Eastman Dental Institute Unit of Periodontology where she was Associate Professor and Director of the MSc Dental Hygiene Programme.  Her most recent roles include Honorary Senior Lecturer at University of Glasgow Dental School, Editor-in-Chief of the International Journal of Dental Hygiene, as well as private practice clinician.

    

9:30 am

• Dentine Hypersensitivity: An Enigma no more
  Dentine Hypersensitivity: An Enigma no more

  The aim of this presentation is to give members of the dental team a greater understanding of dentine hypersensitivity.

  Attendees will be able to:

  • Understand the rationale for a new definition for dentine hypersensitivity

  • Gain knowledge on the associated risk factors of dentine hypersensitivity

  • Understand oral health-related quality of life (OHRQoL) in people with dentine hypersensitivity

  • Gain knowledge on the management of dentine hypersensitivity

  Attendees will understand

  • The relevance and need for a new dentine hypersensitivity definition.

  • How to implement early management strategies for the prevention and management of associated risk factors for dentine hypersensitivity.

  • Know which self-applied and professional treatments have clinical efficacy in the management of dentine hypersensitivity.

   

  GDC Development Outcomes :

  C & D

  • Professor Nicola West
    Professor Nicola West

    Professor

    Professor Nicola West graduated from the University of Wales College of Medicine, Cardiff, and, following the award of her Fellowship of the Royal College of Surgeons of England, completed a PhD at the University of Wales in 1995, focusing on dentine hypersensitivity and tooth surface loss.

    Nicola is Professor of Restorative Dentistry (Periodontology) and Director of the Bristol Clinical Trials Unit at Bristol Dental School, University of Bristol, UK. Professor West leads an internationally recognised research programme, attracting substantial funding from industry, charities, and the National Institute for Health and Care Research (NIHR). Her current research focuses on the relationships between periodontal diseases and systemic conditions, including Alzheimer's disease and Parkinson's disease. She has pioneered innovative clinical periodontal research methodologies and has extensive expertise in the scientific evaluation of oral healthcare products for gingivitis, tooth wear, dentine hypersensitivity, tooth staining, and tooth whitening. Her research also encompasses oral hard and soft tissue augmentation, peri-implant diseases, and implant-related conditions.

    Professor West is a sought-after national and international speaker. Nicola served as President of the British Society of Periodontology and Implant Dentistry (BSP) in 2025, having previously been Honorary Secretary (2013–2020) and the BSP's delegate to the European Federation of Periodontology (EFP) (2013–2019).

    Building on her longstanding contributions to the BSP, Professor West served as Secretary General of the European Federation of Periodontology from 2019 to 2025 and was Treasurer of EuroPerio10 from 2018 to 2021. Nicola is President-Elect of the European Federation of Periodontology for the 2029–2030 term.

    Alongside her academic and research leadership, Professor West has maintained a successful specialist private referral practice in Bristol since 1990, providing advanced periodontal care, hard and soft tissue augmentation, and dental implant therapy.

    

10:00 am

• Antibiotic prophylaxis for infective endocarditis: Practical implementation advice for periodontal care
  Antibiotic prophylaxis for infective endocarditis: Practical implementation advice for periodontal care

  This short talk aims to ensure participants will receive an overview of the key messages contained within the updated 2026 SDCEP Antibiotic Prophylaxis against Infective Endocarditis implementation advice. The session will aim to give practical advice for who are at increased risk of infective endocarditis together with the role of patient values, cardiac teams, potential harms and benefits and shared decision making in determining suitability of antibiotic prophylaxis in periodontal care for these patients.

  1. To give an update on Antibiotic Prophylaxis Against Infective Endocarditis.

  2. To discuss the implementation advice in relation to dental and periodontal treatment.

  3. To consider shared decision making in relation to antibiotic prophylaxis and periodontal care.

  By the end of the talk, the participants will be able to:

  1. List the key messages in the updated SDCEP Antibiotic Prophylaxis Against Infective Endocarditis implementation advice.

  2. Apply the updated implementation advice to the specific individual circumstances of patients who attend for dental and periodontal care and who are at increased risk of infective endocarditis.

  3. Discuss the important role of patient values and preferences, the views of cardiac teams, the potential benefits and harms of antibiotic prophylaxis, and shared decision-making so that patients can make an informed decision about whether antibiotic prophylaxis is appropriate for their individual situation as related to periodontal care.

  GDC Development Outcomes:

  A, B, C & D 

  • Dr Andrew Paterson
    Dr Andrew Paterson

    Dr

    Dr Andrew Paterson was a member of the 2018 Short Life Working group that developed the original implementation advice for antibiotic prophylaxis against infective endocarditis and was chair of the group that produced the 2026 update to the implementation advice. Andrew has had a varied career in clinical dentistry that includes over two decades in a practice setting, NHS consultant posts in Scotland and England in dental and general hospitals together with clinical academic posts in two different Scottish universities. His research interests concern oral health in sub-Saharan Africa. He has managed and continues to manage the oral health issues of patients who are at increased risk of infective endocarditis. Andrew is currently a clinical senior lecturer and honorary consultant in restorative dentistry at the University of Glasgow and NHS Greater Glasgow and Clyde and education lead for restorative dentistry within the BDS course.

    

10:30 am

• Panel Disucssion
  Panel Disucssion

10:45 am

Refreshments and Trade Exhibition

11:15 am

• Vitamin D and periodontal health: from evidence to practice
  Vitamin D and periodontal health: from evidence to practice

  • To provide an evidence-based overview of the biological basis of vitamin D signalling in periodontal health and disease, explore its relevance to the oral–systemic interface, and consider the clinical implications of vitamin D status for periodontal practice.

  1. Outline the biological basis of vitamin D signalling and its role in periodontal immune regulation, epithelial defence and bone homeostasis.

  2. Review current evidence linking serum 25OHD concentrations with periodontal inflammation, tissue destruction and disease progression.

  3. Present findings from a multinational study and emerging research into the role of vitamin D at the oral–systemic interface.

  4. Consider the clinical implications, current limitations of vitamin D assessment and supplementation in periodontal practice.

  By the end of the presentation, participants should be able to:

  1. Explain how vitamin D status may influence periodontal inflammation, host defence and tissue homeostasis.

  2. Interpret current evidence linking vitamin D status with periodontal disease severity and progression.

  3. Recognise clinical, medical and lifestyle factors that may increase a patient’s risk of vitamin D deficiency.

  4. Discuss the potential relevance of vitamin D to periodontal–systemic inflammatory relationships when assessing and managing periodontal patients.

  5. Communicate the current evidence to patients and incorporate vitamin D status into holistic periodontal risk assessment, including appropriate medical liaison, while recognising the limited evidence for supplementation as an adjunctive periodontal treatment.

  GDC Development Outcomes:

  A, C & D

  • Dr Emily Lu
    Dr Emily Lu

    Dr

    Dr Emily Lu is a Senior Clinical Lecturer at King’s College London and an Honorary Consultant in Periodontology at Guy’s Hospital. Her research spans discovery, translational and clinical science, with a particular focus on the role of vitamin D signalling in periodontal immunity, epithelial defence and oral–systemic inflammation. She leads multidisciplinary research investigating the relationships between periodontitis and systemic inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. Her research uses advanced laboratory models and clinical studies to examine how vitamin D influences gingival immune responses, epithelial-barrier function and periodontal health, with the aim of translating biological insights into clinically relevant approaches to disease prevention and patient care.

    

12:00 pm

• Periodontal Disease and Systemic Health: What’s Established, What’s Emerging, and What to Tell Patients
  Periodontal Disease and Systemic Health: What’s Established, What’s Emerging, and What to Tell Patients

  The aim of this lecture is to discuss the current state of the evidence for periodontitis as a risk factor for systemic health outcomes and the implications for clinical practice.

  1. To examine the epidemiology of periodontitis as a risk factor for systemic health outcomes.

  2. To discuss the challenge of periodontal treatment studies and their interpretation.

  3. To discuss the implications of the evidence for clinical practice and patient communication.

  At the end of this lecture you will be able to:

  1. Appreciate the level and limitations of the epidemiologic evidence for periodontitis as a risk factor for systemic health outcomes.

  2. Appreciate the challenges of intervention studies in this field.

   

  GDC Development Outcomes:

  C & D 

  • Professor Thomas Dietrich
    Professor Thomas Dietrich

    Professor

    Thomas Dietrich studied Dentistry and Medicine at Charité, Humboldt University in Berlin. He trained as an Oral Surgeon and worked with the Departments of Periodontology and Oral Surgery at Charité Berlin.

    In 2001 he was awarded a scholarship by the German Academic Exchange Service (DAAD) to study quantitative methods at the Harvard School of Public Health, where he graduated with an MPH in 2002.

    In 2003 he joined the Department of Health Policy and Health Services Research and Department of Periodontology at Boston University Goldman School of Dental Medicine as Assistant and later as Associate Professor, where he pursued his interest in oral epidemiology and clinical outcomes research.

    He was appointed Professor of Oral Surgery at the University of Birmingham in 2007.

    

12:45 pm

• Panel Disucssion
  Panel Disucssion

1:00 pm

Lunch break and Trade Exhibition

2:00 pm

• The Sir Wilfred Fish Prize Winner's presentation and Awards
  The Sir Wilfred Fish Prize Winner's presentation and Awards

2:30 pm

• Aesthetic Zone Implants in Patients with Periodontitis: Evidence and Reality
  Aesthetic Zone Implants in Patients with Periodontitis: Evidence and Reality

  Patients with a history of periodontitis increasingly seek implant-supported rehabilitation in the aesthetic zone. These patients represent a higher-risk group due to their increased susceptibility to biological complications and potential long-term changes of peri-implant tissues. Achieving stable aesthetic results requires careful patient selection, comprehensive risk assessment, and an evidence-based interdisciplinary treatment approach.

  This lecture critically reviews the current evidence regarding implant therapy in periodontally compromised patients and compares scientific data with the realities of everyday clinical practice. Key factors influencing long-term success will be discussed, including periodontal stability before implant placement, risk factors associated with peri-implant disease, timing of implant therapy, hard and soft tissue management, implant positioning, and prosthetic considerations in the aesthetic zone.

  Clinical cases with long-term follow-up will demonstrate how individualised treatment planning, surgical precision, prosthetic integration, and strict supportive periodontal care contribute to predictable functional and aesthetic outcomes. The lecture will also address current limitations of the evidence and provide practical recommendations for managing patient expectations and reducing biological and aesthetic complications.

  Participants will gain a realistic understanding of the opportunities and limitations of implant therapy in periodontally compromised patients and will be able to incorporate current evidence into daily clinical decision-making.

  After this lecture, participants will be able to:

  • Recognise and assess risk factors associated with implant therapy in patients with a history of periodontitis and integrate this knowledge into treatment planning.

  • Apply evidence-based principles for implant placement in the aesthetic zone, including surgical, periodontal, and prosthetic considerations.

  • Understand the importance of prevention, maintenance, and supportive periodontal therapy in preserving peri-implant health and long-term aesthetic outcomes.

  • Improve communication with patients regarding risks, limitations, treatment alternatives, and realistic expectations of implant therapy in high-risk situations.

    GDC Development Outcome:

    A, B & C

  • Professor Markus Schlee
    Professor Markus Schlee

    Professor

    Markus Schlee has run a private practice specializing in periodontology and implantology in Forchheim, Germany, since 1990.

    He holds specialist qualifications in periodontology from the German Society of Periodontology (DGParo) and implantology from the German Society of Implantology (DGI).

    He is a member of numerous professional associations, including Neue Gruppe, DGP, DGI, AAP, IADR, ECDI, DGÄZ, and APW.

    He received his external professorship at Goethe University of Frankfurt in 2015 and is still affiliated. He lectures in the master programs of Goethe University of Frankfurt (MOI), DGI, and DGP.

    He has lectured and published extensively nationally and internationally in periodontology, implantology, periimplantitis, bone augmentation, soft-tissue management, microsurgery, piezosurgery, and esthetics.

    He is the inventor or co-inventor of the Roll Flap, Bone Builder, Wave Technique, Umbrella Technique, GalvoSurge, and GalvoCare.

    

3:15 pm

Refreshments and Trade Exhibition

3:45 pm

• Decision making in Peri-implantitis: Which outcomes are realistic?
  Decision making in Peri-implantitis: Which outcomes are realistic?

  The aim of the lecture is to provide a realistic assessment of treatment outcomes in the management of peri-implant diseases. 

  1. To know and manage the relevant risk factors for peri-implant diseases.

  2. To understand how treatment options and their prognosis vary depending on the clinical findings.

  3. To develop decision-making skills in an evidence-limited setting.

  1. To apply theoretical knowledge in everyday clinical practice

  2. To know the limitations of today’s treatment options and communicate them to the patient

   

  GDC Development Outcomes

  A & C

  • Professor Philipp Sahrmann
    Professor Philipp Sahrmann

    Professor

    After studying at Friedrich-Alexander University Erlangen-Nuremberg from 1997 to 2001, Dr. Philipp Sahrmann worked as an assistant in private practices specializing in periodontology, implantology, and prosthodontics in southern Germany, Italy, and Switzerland.

    Since 2007, he has been working in the Periodontology Group at the Clinic of Preventive Dentistry, Periodontology and Cariology (Head: Prof. Dr. Thomas Attin) at the University of Zurich. Since 2010, in addition to teaching periodontology to dental students, his clinical and research focus as a senior physician has been on anti-inflammatory periodontal and peri-implantitis therapy. The latter is carried out as part of the Interdisciplinary Peri-Implantitis Consultation Zurich, which he co-leads with Prof. R. Jung.

    In 2014, Philipp Sahrmann completed his Master of Advanced Studies in Periodontology at the University of Zurich and his specialization as a periodontist (SSP). In 2015, he completed his habilitation in the field of periodontitis and peri-implantitis.

    In the spring, he worked for three months as a visiting professor at Sapienza University of Rome, in the Section of Periodontology headed by Prof. Dr. Andrea Pilloni.

    From 2019, he worked in the Oral Epidemiology Group before moving to the University Center for Dental Medicine Basel (UZB) in October 2021.

    At the UZB, he is responsible as Program Director for the specialization program leading to the qualification as a specialist in periodontology (SSP), as well as for the periodontal education of dental students.

    At the UZB, he is also Head of the Prophylaxis Department, which comprises 20 dental hygienists and prophylaxis assistants.

    

4:30 pm

• Panel Disucssion
  Panel Disucssion

4:45 pm

• Closing Address
  Closing Address
  • Professor Shauna Culshaw
    Professor Shauna Culshaw

    Professor

    Shauna Culshaw is Professor of Periodontology and Immunology at the University of Glasgow, where she is Dental Clinical Research Facility Lead, Lead for Undergraduate teaching in Periodontics and Deputy Head of the Dental School. Shauna completed specialist training in Periodontics and treats patients referred to Glasgow Dental Hospital with advanced periodontal diseases and provides specialist training to staff. Shauna and her research team investigate the immune response in the oral cavity and the relationship between periodontitis and systemic inflammatory diseases. 

    

5:00 pm

Close